Donald J. Sherrard
#154,913
Most Influential Person Now
Donald J. Sherrard's AcademicInfluence.com Rankings
Donald J. Sherrardphilosophy Degrees
Philosophy
#8726
World Rank
#12160
Historical Rank
Logic
#5752
World Rank
#7177
Historical Rank
Donald J. Sherrardbiology Degrees
Biology
#11877
World Rank
#15308
Historical Rank
Biochemistry
#1990
World Rank
#2131
Historical Rank
Download Badge
Philosophy Biology
Donald J. Sherrard's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biochemistry University of California, San Francisco
Why Is Donald J. Sherrard Influential?
(Suggest an Edit or Addition)Donald J. Sherrard's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Accelerated atherosclerosis in prolonged maintenance hemodialysis. (1974) (1815)
- Serum phosphate levels and mortality risk among people with chronic kidney disease. (2005) (1150)
- Increased risk of hip fracture among patients with end-stage renal disease. (2000) (762)
- The spectrum of bone disease in end-stage renal failure--an evolving disorder. (1993) (708)
- Risk of hip fracture among dialysis and renal transplant recipients. (2002) (399)
- The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. (1982) (343)
- Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. (2005) (337)
- Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. (1984) (326)
- Risk factors for hip fracture among patients with end-stage renal disease. (2000) (313)
- Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. (1989) (313)
- Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. (2001) (311)
- HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. (2002) (305)
- Bone aluminum and histomorphometric features of renal osteodystrophy. (1982) (279)
- Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. (1993) (274)
- Histological quantitation of aluminum in iliac bone from patients with renal failure. (1982) (258)
- The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. (2003) (245)
- Determinants of type and timing of initial permanent hemodialysis vascular access. (2000) (229)
- Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. (1981) (223)
- Survival following parathyroidectomy among United States dialysis patients. (2004) (222)
- Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. (1983) (216)
- Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. (1995) (205)
- Anthropometric measures and risk of death in children with end-stage renal disease. (2000) (198)
- Prevalence of serum lipid abnormalities in chronic hemodialysis. (1977) (188)
- Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. (1977) (181)
- Aluminum loading during total parenteral nutrition. (1982) (175)
- Quantitative histological studies on the pathogenesis of uremic bone disease. (1974) (164)
- BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITION (1980) (163)
- Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. (1981) (163)
- Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. (1984) (153)
- Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. (2002) (147)
- Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. (2002) (146)
- Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. (1985) (142)
- A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. (1998) (139)
- High incidence of neoplasia in uremic patients receiving long-term dialysis. Cancer and long-term dialysis. (1981) (136)
- 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. (1974) (135)
- Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients. (2003) (132)
- Aluminum toxicity. (1983) (120)
- Renal osteodystrophy in diabetic patients. (1993) (118)
- Calcium channel blocker use and mortality among patients with end-stage renal disease. (2002) (108)
- Assessment of a policy to reduce placement of prosthetic hemodialysis access. (2001) (108)
- Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. (2001) (104)
- Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. (1979) (99)
- Bone disease in burn patients (1993) (96)
- Effects of 1-week head-down tilt bed rest on bone formation and the calcium endocrine system. (1992) (96)
- Aluminum‐associated bone disease in chronic renal failure: High prevalence in a long‐term dialysis population (1986) (93)
- Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism. (1978) (91)
- Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. (1988) (90)
- Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. (1997) (90)
- Evidence supporting a role of glucocorticoids in short-term bone loss in burned children (2004) (87)
- Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy. (1986) (85)
- Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. (1992) (85)
- Early deposition of aluminum in bone in diabetic patients on hemodialysis. (1987) (83)
- Avascular necrosis following bone marrow transplantation: a case-control study. (1998) (83)
- Effects of dietary caffeine on renal handling of minerals in adult women. (1990) (82)
- Parathyroidectomy rates among United States dialysis patients: 1990-1999. (2004) (82)
- The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study (2005) (81)
- Reversal of adynamic bone disease by lowering of dialysate calcium. (2006) (77)
- Postheparin plasma triglyceride lipases in chronic hemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism. (1979) (76)
- Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. (1984) (76)
- Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy. (1987) (73)
- Use of calcium carbonate as a phosphate binder in dialysis patients. (1986) (73)
- Aluminum as a factor in the bone disease of long-term parenteral nutrition. (1982) (71)
- Comparison of clinic and home blood pressure levels in essential hypertension and variables associated with clinic-home differences. (1980) (70)
- Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia. (1983) (70)
- Symptomatology, pathophysiology and treatment of the transurethral resection of the prostate syndrome. (1973) (68)
- Racial differences in bone mineral density and bone loss among end-stage renal disease patients. (1999) (68)
- Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients. (1999) (67)
- Blood pressure reductions during self-recording of home blood pressure. (1979) (64)
- Carpal tunnel syndrome in chronic renal dialysis patients. (1981) (64)
- Lithium-induced hyperparathyroidism: an alteration of the "set-point". (1982) (61)
- Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH. (1986) (60)
- Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury. (2007) (60)
- Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. (2003) (59)
- Vitamin D intoxication in an anephric child. (1975) (59)
- Bone histomorphometry of renal osteodystrophy in diabetic patients (1987) (56)
- Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome. (1985) (55)
- First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. (2005) (55)
- Dietary and behavioral risk factors for urolithiasis: potential implications for prevention. (1996) (52)
- Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease. (1988) (52)
- Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions. (1991) (49)
- Serum protein fractionation in normal pregnancy. (1961) (48)
- Metabolic bone disease in adults receiving long-term parenteral nutrition: longitudinal study with regional densitometry and bone biopsy. (1993) (45)
- Psychological correlates of survival on renal dialysis. (1977) (44)
- Acute diphenylhydantoin intoxication. (1968) (43)
- Bone histologic response to deferoxamine in aluminum-related bone disease. (1987) (43)
- Secondary hyperparathyroidism complicated by parathyromatosis. (1996) (43)
- The aplastic form of renal osteodystrophy. (1996) (42)
- Development and reversibility of aluminum-induced bone lesion in the rat. (1987) (41)
- Periarticular tumoral calcinosis and hypercalcemia in a hemodialysis patient without hyperparathyroidism: a case report. (1990) (41)
- Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure. (1980) (41)
- Serum immunoreactive parathyroid hormone and 25-hydroxyvitamin D in patients with uremic bone diseases. (1975) (41)
- Reactivation of inhibited bone acid phosphatase and its significance in bone histomorphometry. (1987) (40)
- Bone biopsy to diagnose hyperoxaluria in patients with renal failure. (1979) (40)
- Bone crystal maturation in renal osteodystrophy in humans. (1974) (39)
- Total body calcium and long-term calcium balance in chronic renal disease. (1973) (39)
- Thyroid function and lipids in patients with chronic renal disease treated by hemodialysis: with comments on the "free thyroxine index". (1979) (38)
- Changes in bone histology after treatment with desferrioxamine. (1986) (34)
- Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis. (2002) (32)
- A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D. (1980) (30)
- Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia. (1983) (30)
- Beta2-microglobulin deposition in bone in chronic renal failure (1991) (29)
- Aluminum and renal osteodystrophy. (1986) (29)
- Septic arthritis in hemodialyzed patients. (1980) (28)
- Aluminum--much ado about something. (1991) (28)
- Pseudohyperparathyroidism. Syndrome associated with aluminum intoxication in patients with renal failure. (1985) (27)
- Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide. (1988) (27)
- Regulation of glutamine metabolism in vitro by bicarbonate ion and pH. (1969) (27)
- Osteonecrosis in patients receiving dialysis: report of two cases and review of the literature. (1990) (26)
- Chronic clofibrate therapy in maintenance hemodialysis patients. (1980) (25)
- A longitudinal study of lipid abnormalities in renal failure. (1983) (25)
- Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy. (1980) (25)
- Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis. (1985) (23)
- Evaluation of intravenous calcium as therapy for osteoporosis. (1973) (23)
- Inert gas analysis of ventilation-perfusion matching during hemodialysis. (1984) (23)
- Aluminum does not accumulate in teenagers and adults on prolonged parenteral nutrition containing free amino acids. (1986) (22)
- BONE DISEASE IN UREMIA (1972) (22)
- Renal Osteodystrophy in Pre-Dialysis Patients: Ethnic Difference? (1999) (22)
- Thirst, relative hypernatremia, and excessive weight gain in maintenance peritoneal dialysis. (1978) (22)
- The effect of prolonged fluoride therapy for osteoporosis: Bone composition and histology (1989) (21)
- Peritoneal dialysis fluid as a source of hepatitis antigen. (1981) (19)
- Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy. (1977) (19)
- Calcimimetics in action. (1998) (18)
- Interactions between dietary caffeine and calcium on calcium and bone metabolism in older women. (1994) (18)
- Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays. (1986) (17)
- Symptomatic hypercalcemia of immobilization in a patient with end-stage renal disease. (2000) (17)
- Bone oxalate in a long-term hemodialysis patient who ingested high doses of vitamin C. (1986) (17)
- Burn-associated bone disease in sheep: roles of immobilization and endogenous corticosteroids. (1996) (17)
- Further evidence supporting the phosphate leak hypothesis of idiopathic hypercalciuria. (1978) (17)
- Dialysis Bone Disease (1974) (16)
- Single-dose tetracycline labeling for bone histomorphometry. (1989) (15)
- Interactions between dietary calcium and caffeine consumption on calcium metabolism in hypertensive humans. (1996) (14)
- The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology. (1990) (13)
- Calcium, Phosphorus Metabolism and Bone Pathology on Long Term Nocturnal Hemodialysis (2001) (13)
- Aluminum-related osteodystrophy. (1989) (12)
- Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels. (1987) (12)
- Toxic effects of aluminum in end-stage renal disease: discussion of a case. (1988) (11)
- Peritoneal dialysis: a temporizing means for hemodialysis patients with subdural hematomas. (1977) (11)
- BONE ALUMINIUM AND HISTOMORPHOMETRIC FEA-TURES OF RENAL OSTEODYSTROPHY (1982) (11)
- Beta 2-microglobulin deposition in bone in chronic renal failure. (1991) (10)
- Effect of high carbohydrate feeding with dextrose or sucrose on adipose tissue lipoprotein lipase activity and plasma triglyceride levels in hemodialysis patients. (1979) (9)
- Vocational adjustment and survival on chronic hemodialysis. (1981) (9)
- Aplastic bone: a nondisease of medical progress. (1995) (9)
- Renal Osteodystrophy: Past and Present (1996) (9)
- Idiopathic hypercalciuria: The 'phosphate leak' hypothesis and the effects of oral phosphate supplement (1977) (8)
- RENAL OSTEODYSTROPHY (1964) (8)
- Achievement of proposed NKF-K/DOQI Bone Metabolism and Disease targets Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism (2003) (8)
- Vasectomy is associated with an increased risk for urolithiasis. (1997) (8)
- Renal osteodystrophy and aging. (2009) (7)
- Hand dysfunction due to carpal tunnel syndrome: a common sequela of dialysis. (1979) (7)
- Peritoneal dialysis, a feasible alternative. (1973) (6)
- Psychological assessment of renal dialysis patients using standard psychometric techniques. (1980) (6)
- Aluminum and TPN-related bone disease. (1992) (6)
- Vocational adjustment, psychological assessment and survival on hemodialysis. (1978) (5)
- Manipulating the calcium receptor. (2002) (5)
- An improved method for the microdetermination of glutamine in plasma and urine. (1969) (5)
- Deaths and injuries caused by landmines (1995) (4)
- Calcium balance in uremia: longitudinal study of long-term survivors. (1985) (4)
- Improved lipid profiles with bicarbonate dialysis. (1980) (4)
- Dialysis bone disease. A quantitative histologic study. (1974) (3)
- Metabolic causes of nephrolithiasis. (1983) (3)
- 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats (1984) (3)
- Near-total parathyroidectomy in chronic dialysis patients. (1976) (3)
- Advances in peritoneal dialysis. (1975) (3)
- Letter: The myth of aluminum toxicity. (1974) (3)
- Do everything you can. (1990) (2)
- Response to Drs Koo and Chesney (1992) (2)
- Bone aluminum accumulation in hemodialysis patients: a longitudinal perspective. (1988) (2)
- Simple Test for Hypercalciuria (1975) (2)
- Infections in haemodialysis patients. (1970) (2)
- INFECTIONS IN HÆMODIALYSIS PATIENTS (1970) (2)
- Long-term results in patients using a povidone-iodine connection device in peritoneal dialysis (1982) (1)
- Should vitamin D analogs be the therapy of preference for ESRD patients with secondary hyperparathyroidism (2001) (1)
- Nephrectomy for renovascular hypertension in azotemic patients. (1975) (1)
- Hypercalcemia During Treatment of Uremic Patients with 1,25(OH)2D3: Analysis of 43 Cases (1979) (1)
- Atherosclerosis and hemodialysis. (1979) (1)
- Control of Renal Bone Disease (1994) (1)
- Letter: Treatment of hypertensive crises with diazoxide. (1975) (1)
- Hypercalcemia and hypertension. (1977) (1)
- Bone disease in burn patients: Roles of aluminum and bed rest (1992) (1)
- Aluminum induced bone disease: Clinical features (1990) (1)
- The role of aluminum in renal osteodystrophy. (1993) (1)
- Response to 'The low-calcium concentration of dialysate induced a marked increase of serum parathyroid hormone level in a continuous ambulatory peritoneal dialysis patient'. (2007) (1)
- The Role of Blood Pressure Regulation in Uremia (1985) (0)
- Reply to P Chappuis et al (1991) (0)
- Recommendations for viral hepatitis. (1986) (0)
- The pathogenesis and treatment of kidney stones. (1993) (0)
- Subject Index, Vol. 27, 1981 (1981) (0)
- Correction: Calcium in Dialysate (1974) (0)
- Former Fellows Contributing to the Festschrift (2004) (0)
- Contents, Vol. 18, 1977 (1977) (0)
- Subject Index, Vol. 18, 1977 (1977) (0)
- LOW SERUM CALCITRIOL CONCENTRATIONS AND REDUCED BONE FORMATION IN PATIENTS WITH SEVERE BURNS (1991) (0)
- Royal College of Physicians of Endinburgh. (1981) (0)
- Specialty Conferenc Metabolic Causes of Nephrolithiasis (0)
- Acute renal failure. (1996) (0)
- ALUMINUM-RELATED HONE DISEASE AND SERUM ALUMINUM IN CHILDREN UNDERGOING CAPD (1984) (0)
- Uremic hyperlipidemia: the nature of the problem. (1977) (0)
- Relative costs of ticrynafen and thiazides. (1979) (0)
- Manuscripts in Forthcoming Issues (1974) (0)
- [Rehabilitation of 240 patients with kidney diseases in a home dialysis program]. (1972) (0)
- THIAZIDES AND RENAL STONES (1981) (0)
This paper list is powered by the following services:
